Nakano, Shiori
Yamaji, Taiki http://orcid.org/0000-0002-4799-8782
Hidaka, Akihisa
Shimazu, Taichi
Shiraishi, Kouya
Kuchiba, Aya
Saito, Masahiro
Kunishima, Fumihito
Nakaza, Ryouji
Kohno, Takashi
Sawada, Norie
Inoue, Manami
Tsugane, Shoichiro
Iwasaki, Motoki
Funding for this research was provided by:
National Cancer Center Research and Development Fund (23-A-31 [toku], 26-A-2, 29-A-4, 2020-J-4, 2020-J-2)
Ministry of Health, Labour and Welfare (a Grant-in-Aid for Cancer Research)
Japan Agency for Medical Research and Development (JP19ck0106266, JP22ck0106551)
Article History
Received: 15 January 2024
Accepted: 13 June 2024
First Online: 20 June 2024
Declarations
:
: None of the authors report conflicts of interest related to this article. Full disclosures are as follows; Kohno has received personal fees outside of this work from Chugai Pharmaceutical, Eli Lilly Japan, and Sysmex Corporation; and a patent fee from ThermoFisher Scientific.
: Participants were informed of the JPHC study objectives, and completing the questionnaire indicated consent to participate in the JPHC study. Before the initiation of tissue collection, information regarding this study was posted on our center’s website to provide participants with the opportunity to opt out at any time. The comprehensive study protocol, including this study, was approved by the Institutional Review Board of the National Cancer Center, Tokyo, Japan (Approval No. 2014-214). All the procedures complied with the principles of the Declaration of Helsinki.